Secondary neoplasms observed in the study population
| Leukemia and lymphoma n = 23 . | CNS tumors n = 13 . | Other neoplasm n = 16 . |
|---|---|---|
| Acute myeloid leukemia (16;1) (3.9 y) Chronic myeloid leukemia (1;1) (2.3 y) Hodgkin's disease (4;3) (2.4 y) Non-Hodgkin's lymphoma (2;2) (2.5 y) | Glioblastoma (4;2) (5.5 y) Astrocytoma (4;2) (8.5 y) CNS-PNET (3;–) (11.7 y) Meningioma (2;2) (9.5 y) | Thyroid cancer (3;3) (9.2 y) Malignant histiocytosis (2;–) (1.2 y) Basal cell carcinoma (2;2) (13.5 y) Epithelial carcinoma (1;–) Squamous cell carcinoma (1;1) Malignant teratoma (1;1) Mucoepidermoid carcinoma (1;1) Melanoma (1;1) Nephroblastoma (1;–) Osteosarcoma (1;1) PNET (1;1) Unknown secondary tumor with lung metastasis (1;?) |
| Leukemia and lymphoma n = 23 . | CNS tumors n = 13 . | Other neoplasm n = 16 . |
|---|---|---|
| Acute myeloid leukemia (16;1) (3.9 y) Chronic myeloid leukemia (1;1) (2.3 y) Hodgkin's disease (4;3) (2.4 y) Non-Hodgkin's lymphoma (2;2) (2.5 y) | Glioblastoma (4;2) (5.5 y) Astrocytoma (4;2) (8.5 y) CNS-PNET (3;–) (11.7 y) Meningioma (2;2) (9.5 y) | Thyroid cancer (3;3) (9.2 y) Malignant histiocytosis (2;–) (1.2 y) Basal cell carcinoma (2;2) (13.5 y) Epithelial carcinoma (1;–) Squamous cell carcinoma (1;1) Malignant teratoma (1;1) Mucoepidermoid carcinoma (1;1) Melanoma (1;1) Nephroblastoma (1;–) Osteosarcoma (1;1) PNET (1;1) Unknown secondary tumor with lung metastasis (1;?) |
In parentheses: number of patients and number of patients alive.
Median time span from diagnosis of ALL to the diagnosis of SN in years.